Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States.

ABSTRACT:

Importance

In 2005, the US Advisory Committee on Immunization Practices recommended routine quadrivalent meningococcal conjugate (MenACWY) vaccine for all adolescents aged 11 to 12 years, and in 2010, a booster dose for adolescents aged 16 years. Measuring the association between MenACWY vaccination and the incidence of meningococcal disease in adolescents is critical for evaluating the adolescent vaccination program and informing future vaccine policy.

Objective

To describe the association between MenACWY vaccination and the incidence of meningococcal disease in US adolescents.

Design, setting, and participants

In this cohort study, analysis of surveillance data included all confirmed and probable cases of Neisseria meningitidis reported to the National Notifiable Di

SUBMITTER: Mbaeyi S 

PROVIDER: S-EPMC7372499 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature